Alan M Garber, M.D., Ph.D.

Concepts (566)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Health Expenditures	17	2018	2353	1.580	Why?
Cost-Benefit Analysis	62	2016	5491	1.570	Why?
Health Care Costs	18	2014	3240	1.090	Why?
Comparative Effectiveness Research	4	2011	708	1.010	Why?
Medicare	14	2018	6732	0.960	Why?
Technology Assessment, Biomedical	7	2007	306	0.960	Why?
Quality-Adjusted Life Years	29	2016	1722	0.710	Why?
Health Services Research	8	2009	1811	0.690	Why?
Biomedical Technology	5	2006	210	0.690	Why?
Diffusion of Innovation	4	2016	726	0.640	Why?
Natural Language Processing	4	2009	1144	0.640	Why?
Colectomy	2	2012	687	0.550	Why?
Markov Chains	15	2016	965	0.530	Why?
Economic Competition	2	2016	217	0.510	Why?
Cost Control	4	2013	628	0.510	Why?
Mass Screening	18	2006	5424	0.490	Why?
Defibrillators, Implantable	6	2010	1488	0.480	Why?
Health Policy	10	2016	2680	0.480	Why?
Information Storage and Retrieval	3	2009	819	0.470	Why?
United States	63	2018	72202	0.440	Why?
Vaginal Smears	4	2001	499	0.440	Why?
Hypercholesterolemia	7	2000	1142	0.440	Why?
Industry	2	2006	364	0.430	Why?
Drug Industry	3	2009	788	0.430	Why?
Cholesterol	8	2000	2902	0.430	Why?
Drug Approval	3	2009	811	0.430	Why?
Evidence-Based Medicine	6	2005	3685	0.420	Why?
Multimedia	5	2005	75	0.410	Why?
Utilization Review	2	2005	382	0.410	Why?
Sulfonylurea Compounds	2	2011	219	0.410	Why?
Randomized Controlled Trials as Topic	11	2016	10180	0.400	Why?
Death, Sudden, Cardiac	3	2018	1554	0.390	Why?
Gaucher Disease	7	1998	110	0.390	Why?
Glucagon-Like Peptide 1	2	2011	363	0.380	Why?
Coronary Disease	14	2000	5919	0.380	Why?
Reimbursement, Incentive	4	2013	540	0.380	Why?
Mesalamine	1	2011	135	0.370	Why?
Colonic Pouches	1	2012	122	0.370	Why?
Health Care Reform	5	2016	1245	0.360	Why?
Kyphoplasty	1	2011	44	0.360	Why?
Decision Making	4	2011	3923	0.360	Why?
Organizational Policy	5	2008	432	0.350	Why?
Technology, High-Cost	1	2010	32	0.350	Why?
Azathioprine	1	2011	356	0.350	Why?
Vertebroplasty	1	2011	78	0.340	Why?
Androgen Antagonists	3	2012	1407	0.340	Why?
Low Back Pain	1	2018	982	0.340	Why?
Colitis, Ulcerative	2	2012	1922	0.340	Why?
Health Services	3	2013	752	0.340	Why?
Private Sector	3	2013	397	0.330	Why?
Academies and Institutes	1	2011	318	0.330	Why?
Insurance Coverage	4	2008	1934	0.330	Why?
Watchful Waiting	2	2012	491	0.330	Why?
Osteoporosis	2	2011	1603	0.320	Why?
Decision Support Techniques	16	2014	1998	0.320	Why?
Radiotherapy, Intensity-Modulated	2	2012	801	0.320	Why?
Capsule Endoscopy	1	2009	100	0.310	Why?
Myocardial Infarction	10	2014	11453	0.310	Why?
Glucosylceramidase	4	1994	126	0.310	Why?
Device Approval	1	2010	163	0.310	Why?
Insurance Claim Reporting	2	2008	165	0.300	Why?
Equipment and Supplies	2	2010	273	0.300	Why?
Fast Foods	1	2010	210	0.290	Why?
Taxes	1	2010	221	0.290	Why?
Hypoglycemic Agents	7	2014	3076	0.290	Why?
Tomography	1	2009	411	0.290	Why?
Decision Making, Organizational	2	2004	136	0.280	Why?
Prostatectomy	2	2012	1821	0.280	Why?
Heparin, Low-Molecular-Weight	2	1999	344	0.280	Why?
Preimplantation Diagnosis	1	2009	143	0.280	Why?
Pattern Recognition, Automated	2	2009	996	0.270	Why?
Government Regulation	2	2010	524	0.270	Why?
Sodium, Dietary	1	2010	425	0.270	Why?
Humans	136	2018	760437	0.270	Why?
Nutrition Policy	1	2010	471	0.260	Why?
Cystic Fibrosis	3	2009	1284	0.250	Why?
Delivery of Health Care	4	2016	5332	0.250	Why?
Pharmacogenetics	1	2009	675	0.240	Why?
Alendronate	1	2006	175	0.240	Why?
Efficiency	2	2008	476	0.240	Why?
Insurance, Health	4	2008	2491	0.240	Why?
Models, Econometric	4	2011	216	0.240	Why?
Terminally Ill	1	2007	240	0.240	Why?
Costs and Cost Analysis	13	2010	1668	0.240	Why?
Antibodies, Monoclonal	3	2012	9176	0.240	Why?
Spinal Fractures	1	2011	705	0.230	Why?
Long-Term Care	2	2004	633	0.230	Why?
Uterine Cervical Neoplasms	4	2001	2016	0.230	Why?
Insurance Claim Review	2	2008	735	0.230	Why?
Teriparatide	1	2006	227	0.230	Why?
Diabetes Mellitus, Type 2	6	2014	12127	0.230	Why?
Terminal Care	2	2007	1751	0.220	Why?
Intestine, Small	1	2009	1205	0.220	Why?
Protein C	1	2003	133	0.220	Why?
Disease	1	2008	672	0.210	Why?
Transcutaneous Electric Nerve Stimulation	1	2004	170	0.210	Why?
Activities of Daily Living	4	2008	2420	0.200	Why?
Monte Carlo Method	5	2014	1257	0.200	Why?
Infertility, Female	1	2008	758	0.200	Why?
Heart Arrest	2	2003	1502	0.200	Why?
Prostatic Neoplasms	4	2012	11095	0.200	Why?
Aged	48	2018	168840	0.200	Why?
Sensitivity and Specificity	20	2010	14661	0.200	Why?
Reimbursement Mechanisms	1	2007	664	0.200	Why?
Orphan Drug Production	2	1992	48	0.200	Why?
Drug Costs	3	2013	1179	0.190	Why?
Heparin	2	1999	1633	0.190	Why?
Research Support as Topic	3	2011	697	0.190	Why?
Tibial Fractures	1	2004	268	0.190	Why?
Blood Glucose	4	2014	6380	0.190	Why?
Patient-Centered Care	1	2011	1416	0.190	Why?
Orchiectomy	2	2000	463	0.190	Why?
Terminology as Topic	1	2008	1534	0.190	Why?
Drug Discovery	1	2009	1054	0.190	Why?
Angioplasty	2	2014	354	0.180	Why?
Financing, Personal	2	2013	309	0.180	Why?
Practice Guidelines as Topic	5	2005	7380	0.180	Why?
Quality of Life	11	2012	13338	0.180	Why?
Streptococcus agalactiae	1	2002	337	0.180	Why?
Aircraft	1	2001	125	0.180	Why?
Pharmaceutical Preparations	1	2009	1087	0.180	Why?
Diethylstilbestrol	1	2000	87	0.180	Why?
Thiazolidinediones	2	2014	461	0.180	Why?
Diagnostic Techniques and Procedures	1	2002	219	0.180	Why?
Laparoscopy	2	2011	2035	0.180	Why?
California	8	2008	1426	0.180	Why?
Body Weight	1	2011	4614	0.170	Why?
Endometriosis	1	2008	869	0.170	Why?
Models, Economic	3	2013	716	0.170	Why?
Influenza Vaccines	3	2014	763	0.170	Why?
Influenza, Human	4	2014	1517	0.170	Why?
Venous Thrombosis	2	1999	1297	0.170	Why?
Managed Care Programs	1	2004	940	0.160	Why?
Intensive Care Units	3	2008	3742	0.160	Why?
Bone Density Conservation Agents	1	2006	795	0.160	Why?
Cataract Extraction	1	2003	466	0.160	Why?
Research	3	2011	1977	0.160	Why?
Ultraviolet Therapy	1	1998	84	0.150	Why?
Mass Vaccination	2	2009	109	0.150	Why?
Electric Countershock	1	2001	533	0.150	Why?
Biological Products	1	2007	911	0.150	Why?
Anticoagulants	4	2016	4806	0.150	Why?
Health Care Rationing	1	2001	437	0.150	Why?
Streptococcal Infections	1	2002	616	0.150	Why?
Female	61	2018	391875	0.150	Why?
Osteogenesis	1	2004	1273	0.150	Why?
Age Factors	9	2018	18379	0.150	Why?
Pregnancy Outcome	1	2008	2916	0.150	Why?
Male	57	2018	360035	0.140	Why?
Caregivers	2	2011	2232	0.140	Why?
Healthcare Disparities	1	2013	3344	0.140	Why?
Attitude to Health	3	2008	2025	0.140	Why?
Crohn Disease	1	2009	2278	0.140	Why?
Interviews as Topic	5	2005	2683	0.140	Why?
Life Expectancy	6	2013	1240	0.140	Why?
Quality Assurance, Health Care	4	2008	2167	0.140	Why?
State Medicine	2	2008	214	0.130	Why?
Decision Trees	6	2016	504	0.130	Why?
Receptor, erbB-2	1	2007	2553	0.130	Why?
Survival Analysis	7	2007	10075	0.130	Why?
Government Agencies	1	1996	160	0.130	Why?
Disease Outbreaks	3	2010	1762	0.130	Why?
Financing, Government	2	2009	472	0.130	Why?
Stroke	5	2016	9745	0.130	Why?
Antineoplastic Agents, Hormonal	2	2000	1517	0.120	Why?
Polymerase Chain Reaction	2	2002	6086	0.120	Why?
Publishing	1	2002	833	0.120	Why?
Geriatric Assessment	5	2008	1409	0.120	Why?
Medical Informatics	1	2002	733	0.120	Why?
Quality of Health Care	3	2010	4316	0.120	Why?
Recombinant Proteins	2	2007	6525	0.120	Why?
Software	5	2008	4426	0.120	Why?
Dermatologic Agents	1	1998	311	0.120	Why?
Hyperlipidemias	2	2002	771	0.120	Why?
Tomography, Emission-Computed, Single-Photon	1	1999	1066	0.110	Why?
Hospitals, Veterans	1	1996	395	0.110	Why?
Academic Medical Centers	1	2004	2757	0.110	Why?
Artificial Intelligence	1	2008	2568	0.110	Why?
Socioeconomic Factors	4	2018	7817	0.110	Why?
Treatment Outcome	18	2014	64591	0.110	Why?
Hypolipidemic Agents	1	1998	609	0.110	Why?
Brachytherapy	2	2012	1223	0.110	Why?
Health Services for the Aged	2	2004	259	0.110	Why?
Coronary Angiography	2	2010	4468	0.110	Why?
Anti-Inflammatory Agents, Non-Steroidal	1	2003	2272	0.110	Why?
Hospital Costs	3	2007	948	0.110	Why?
Visual Acuity	1	2003	2662	0.110	Why?
United States Department of Veterans Affairs	2	2006	923	0.110	Why?
Renal Dialysis	3	2008	1795	0.110	Why?
Anticholesteremic Agents	1	2000	966	0.110	Why?
Middle Aged	33	2013	220382	0.100	Why?
Estrogen Replacement Therapy	2	2002	1208	0.100	Why?
Survivors	1	2003	2369	0.100	Why?
Attitude to Computers	2	2005	195	0.100	Why?
Human Growth Hormone	2	2008	638	0.100	Why?
Atrial Appendage	1	2016	283	0.100	Why?
Public Policy	1	1996	559	0.100	Why?
Risk Factors	20	2018	74055	0.100	Why?
Cost of Illness	4	2012	1931	0.100	Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors	2	2013	3243	0.100	Why?
Methotrexate	1	1998	1720	0.100	Why?
Prenatal Diagnosis	2	1991	1265	0.100	Why?
Rhabdomyolysis	1	2013	152	0.100	Why?
Health Status Indicators	3	2008	968	0.100	Why?
Coronary Artery Bypass	3	2014	2188	0.100	Why?
American Recovery and Reinvestment Act	1	2011	72	0.100	Why?
Hospitals	1	2005	3873	0.100	Why?
Patient Satisfaction	3	2011	3457	0.100	Why?
Choice Behavior	1	1997	823	0.100	Why?
Geography	1	2013	658	0.090	Why?
Pravastatin	1	2013	392	0.090	Why?
Genetic Testing	3	2006	3535	0.090	Why?
Combined Modality Therapy	2	2014	8522	0.090	Why?
United States Food and Drug Administration	2	2010	1663	0.090	Why?
Aged, 80 and over	13	2018	58859	0.090	Why?
Psoriasis	1	1998	937	0.090	Why?
Pregnancy Complications, Infectious	1	2002	2151	0.090	Why?
Health Services Accessibility	2	2005	5421	0.090	Why?
beta-Alanine	1	2010	81	0.090	Why?
Sex Factors	5	2018	10538	0.090	Why?
Life Support Care	1	2011	226	0.090	Why?
Cerebrovascular Disorders	1	1997	1475	0.090	Why?
Jurisprudence	1	2010	109	0.090	Why?
Nephrons	1	2011	168	0.090	Why?
Adult	29	2010	220781	0.090	Why?
Expressed Emotion	1	2010	92	0.080	Why?
Carotid Stenosis	1	1997	860	0.080	Why?
Risk	3	2018	9605	0.080	Why?
Equipment Failure	2	2010	578	0.080	Why?
Eligibility Determination	1	2013	420	0.080	Why?
Sepsis	1	2003	2583	0.080	Why?
Diabetes Complications	2	2014	1317	0.080	Why?
Subject Headings	1	2008	17	0.080	Why?
Breast Neoplasms	2	2007	20985	0.080	Why?
Antihypertensive Agents	2	1998	2018	0.080	Why?
Therapeutic Equivalency	1	2009	134	0.080	Why?
Electrocardiography	3	1999	6380	0.080	Why?
Influenza A Virus, H5N1 Subtype	1	2009	113	0.080	Why?
Probability	3	2003	2476	0.080	Why?
Object Attachment	1	2011	326	0.080	Why?
Public Health	1	2002	2665	0.080	Why?
Residence Characteristics	1	2018	2087	0.080	Why?
Physicians	2	2004	4586	0.080	Why?
Pregnancy, Multiple	1	2009	215	0.080	Why?
Drug Resistance, Microbial	2	1989	857	0.080	Why?
Drugs, Generic	2	2014	447	0.080	Why?
Diet, Sodium-Restricted	1	2010	291	0.080	Why?
Psychometrics	1	1998	3063	0.080	Why?
Observation	1	2010	310	0.070	Why?
Multivariate Analysis	5	2005	12054	0.070	Why?
Standard of Care	1	2011	550	0.070	Why?
Twins	1	2009	339	0.070	Why?
Gastrointestinal Agents	1	2012	510	0.070	Why?
Coronary Artery Disease	3	2014	6388	0.070	Why?
Logistic Models	4	2010	13240	0.070	Why?
Athletic Performance	1	2008	109	0.070	Why?
Exercise Test	2	1999	2127	0.070	Why?
Hypoglycemia	2	2010	884	0.070	Why?
Decision Making, Computer-Assisted	2	1998	146	0.070	Why?
Forecasting	3	2011	2925	0.070	Why?
Warfarin	2	2016	1483	0.070	Why?
Echocardiography	1	1999	4981	0.070	Why?
Smoking Cessation	1	1998	2053	0.070	Why?
Kidney Failure, Chronic	3	2013	2462	0.070	Why?
Health Services Needs and Demand	2	2004	1403	0.070	Why?
Evaluation Studies as Topic	2	2007	1627	0.070	Why?
Pregnancy Rate	1	2009	648	0.070	Why?
Blastocyst	1	2009	433	0.070	Why?
Computer Literacy	2	2005	44	0.070	Why?
Public Sector	1	2007	267	0.060	Why?
Canada	2	2008	2119	0.060	Why?
Influenza A Virus, H1N1 Subtype	1	2009	445	0.060	Why?
Nephrectomy	1	2011	934	0.060	Why?
Clinical Trials as Topic	5	2014	7996	0.060	Why?
Heart Diseases	3	2002	2785	0.060	Why?
Hospitalization	4	2013	10698	0.060	Why?
Anthrax Vaccines	1	2005	17	0.060	Why?
Exercise	4	2008	5874	0.060	Why?
Benzimidazoles	1	2010	855	0.060	Why?
Incidental Findings	1	2010	697	0.060	Why?
Ischemic Attack, Transient	1	2010	878	0.060	Why?
Clinical Protocols	1	1991	1438	0.060	Why?
Atrial Fibrillation	2	2016	5126	0.060	Why?
Algorithms	4	2009	14002	0.060	Why?
Disease Progression	4	2013	13484	0.060	Why?
Regression Analysis	2	2010	6340	0.060	Why?
Geriatric Nursing	1	2005	39	0.060	Why?
Anthrax	1	2005	87	0.060	Why?
Computer Simulation	2	2010	6230	0.060	Why?
Bioterrorism	1	2005	144	0.060	Why?
Direct Service Costs	2	2014	59	0.060	Why?
Models, Cardiovascular	1	2010	985	0.060	Why?
Double-Blind Method	3	2011	12320	0.060	Why?
Diagnostic Imaging	1	2018	3541	0.060	Why?
Rate Setting and Review	1	2004	41	0.060	Why?
Health Facility Merger	1	2004	47	0.060	Why?
Adjuvants, Immunologic	1	2009	1035	0.060	Why?
Molecular Diagnostic Techniques	1	2009	611	0.060	Why?
Abortion, Spontaneous	1	2009	533	0.060	Why?
Antipsychotic Agents	1	1997	3066	0.060	Why?
Gonadotropin-Releasing Hormone	2	2000	1147	0.060	Why?
Economics	1	2004	141	0.060	Why?
Recurrence	4	2000	8466	0.060	Why?
Product Surveillance, Postmarketing	1	2008	452	0.060	Why?
Physician Executives	1	2004	134	0.060	Why?
Time Factors	6	2013	39947	0.060	Why?
Commerce	1	2009	604	0.060	Why?
Capitation Fee	1	2004	116	0.060	Why?
Models, Theoretical	3	2014	3576	0.050	Why?
Japan	1	2008	1366	0.050	Why?
Patient Care	1	2009	621	0.050	Why?
Drug Administration Schedule	2	2007	4849	0.050	Why?
Boronic Acids	1	2007	914	0.050	Why?
Cardiovascular Diseases	1	2009	15476	0.050	Why?
APACHE	1	2003	267	0.050	Why?
Hypertension	4	2013	8527	0.050	Why?
Genes, BRCA2	1	2006	602	0.050	Why?
Heart Valve Prosthesis Implantation	1	2013	1554	0.050	Why?
Cohort Studies	5	2007	41366	0.050	Why?
Myocardial Revascularization	2	2003	792	0.050	Why?
Pregnancy	4	2009	29831	0.050	Why?
Genes, BRCA1	1	2006	765	0.050	Why?
Heterozygote	1	2009	2798	0.050	Why?
New York City	1	2004	730	0.050	Why?
Affect	1	2010	1483	0.050	Why?
Fee-for-Service Plans	2	2004	699	0.050	Why?
National Institutes of Health (U.S.)	3	1996	793	0.050	Why?
Social Responsibility	1	2005	386	0.050	Why?
Tomography, X-Ray Computed	2	2010	20551	0.050	Why?
Platelet Aggregation Inhibitors	1	2014	2750	0.050	Why?
Mortality	3	1999	2897	0.050	Why?
Developed Countries	1	2004	445	0.050	Why?
Patient Protection and Affordable Care Act	1	2011	1185	0.050	Why?
Pyrazines	1	2007	1199	0.050	Why?
Patient Selection	2	2013	4240	0.050	Why?
Reproducibility of Results	7	2005	20078	0.050	Why?
Drug Therapy, Combination	2	2014	6297	0.050	Why?
Bacterial Infections	1	1989	1406	0.050	Why?
Fertilization in Vitro	1	2009	1292	0.050	Why?
Acute Coronary Syndrome	1	2014	2191	0.050	Why?
Fibrinolytic Agents	1	2010	2082	0.050	Why?
Europe	1	2008	3419	0.050	Why?
Aortic Valve Stenosis	1	2013	2008	0.050	Why?
Survival Rate	4	2016	12698	0.040	Why?
Bacteria	2	1989	2217	0.040	Why?
Cross Infection	1	1989	1438	0.040	Why?
Radiography	2	2009	6963	0.040	Why?
Data Collection	2	2002	3321	0.040	Why?
Anti-Bacterial Agents	2	1989	7424	0.040	Why?
Antibiotic Prophylaxis	1	2005	640	0.040	Why?
Sex Distribution	1	2005	2281	0.040	Why?
Analysis of Variance	2	1999	6230	0.040	Why?
Ventricular Fibrillation	1	2002	537	0.040	Why?
Thallium Radioisotopes	1	1999	138	0.040	Why?
Hospitals, Teaching	1	1984	1155	0.040	Why?
Diabetes Mellitus, Type 1	1	1994	3439	0.040	Why?
Dipyridamole	1	1999	140	0.040	Why?
Labor, Obstetric	1	2002	323	0.040	Why?
Dobutamine	1	1999	116	0.040	Why?
Self Concept	1	2005	1043	0.040	Why?
Acute Disease	2	2008	7230	0.040	Why?
Technetium Tc 99m Sestamibi	1	1999	174	0.040	Why?
Hemorrhage	3	2014	3414	0.040	Why?
Medicare Part C	1	2004	327	0.040	Why?
Magnetic Resonance Imaging	1	2006	36362	0.040	Why?
Histamine H2 Antagonists	1	2000	166	0.040	Why?
Schizophrenia	1	1997	6927	0.040	Why?
Needs Assessment	1	2004	1139	0.040	Why?
Benchmarking	1	2005	1045	0.040	Why?
Chemotherapy, Adjuvant	1	2007	3512	0.040	Why?
Synostosis	1	1998	43	0.040	Why?
Comorbidity	2	2013	10494	0.040	Why?
Nursing Homes	1	2006	1081	0.040	Why?
Postoperative Period	1	2003	1807	0.040	Why?
Image Processing, Computer-Assisted	2	2009	8967	0.040	Why?
Cities	2	2014	543	0.040	Why?
Akathisia, Drug-Induced	1	1997	67	0.040	Why?
Catheter Ablation	1	2011	2752	0.040	Why?
Primary Prevention	2	2013	1186	0.040	Why?
Health Care Surveys	1	2004	2425	0.040	Why?
Incidence	3	2013	21322	0.040	Why?
Predictive Value of Tests	3	2002	15257	0.040	Why?
Models, Statistical	2	2005	5078	0.040